A032790 Stock Overview
Mgen Solutions Co.,Ltd. manufactures and sells medical equipment.
| Snowflake Score | |
|---|---|
| Valuation | 1/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
Mgen Solutions Co., Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₩2,065.00 |
| 52 Week High | ₩4,195.00 |
| 52 Week Low | ₩1,297.00 |
| Beta | 0.15 |
| 1 Month Change | 14.91% |
| 3 Month Change | 41.83% |
| 1 Year Change | -25.99% |
| 3 Year Change | n/a |
| 5 Year Change | -76.93% |
| Change since IPO | -84.82% |
Recent News & Updates
Shareholder Returns
| A032790 | KR Commercial Services | KR Market | |
|---|---|---|---|
| 7D | 9.0% | 3.6% | 0.5% |
| 1Y | -26.0% | -9.3% | 4.7% |
Return vs Industry: A032790 underperformed the KR Commercial Services industry which returned -9.3% over the past year.
Return vs Market: A032790 underperformed the KR Market which returned 4.7% over the past year.
Price Volatility
| A032790 volatility | |
|---|---|
| A032790 Average Weekly Movement | 14.6% |
| Commercial Services Industry Average Movement | 3.8% |
| Market Average Movement | 5.3% |
| 10% most volatile stocks in KR Market | 11.8% |
| 10% least volatile stocks in KR Market | 2.4% |
Stable Share Price: A032790's share price has been volatile over the past 3 months.
Volatility Over Time: A032790's weekly volatility (15%) has been stable over the past year, but is still higher than 75% of KR stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| n/a | 86 | n/a | www.mgenplus.com |
Mgen Solutions Co.,Ltd. manufactures and sells medical equipment. The company offers bio organ a transformation and cloning organs transplanted into human being; optical device for printers; communication network for broadcasting communication services; and medical equipment and devices.
Mgen Solutions Co., Ltd. Fundamentals Summary
| A032790 fundamental statistics | |
|---|---|
| Market cap | ₩86.23b |
| Earnings (TTM) | -₩21.26b |
| Revenue (TTM) | ₩90.53b |
1.0x
P/S Ratio-4.1x
P/E RatioIs A032790 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| A032790 income statement (TTM) | |
|---|---|
| Revenue | ₩90.53b |
| Cost of Revenue | ₩82.05b |
| Gross Profit | ₩8.49b |
| Other Expenses | ₩29.74b |
| Earnings | -₩21.26b |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | -509.11 |
| Gross Margin | 9.37% |
| Net Profit Margin | -23.48% |
| Debt/Equity Ratio | 21.3% |
How did A032790 perform over the long term?
See historical performance and comparison